Product
MM09-MG01(30.000-30.000)
1 clinical trial
4 indications
Indication
Allergic RhinoconjunctivitisIndication
Allergic RhinitisIndication
House Dust Mite AllergyIndication
Pollen AllergyClinical trial
Prospective, Randomized, Placebo-controlled, Multi-center Trial Comparing the Efficacy and Safety of Subcutaneous Immunotherapy With a Mixture of Grasses and Mites at Adequate Doses Versus Monotherapy, for the Treatment of AllergyStatus: Terminated, Estimated PCD: 2023-10-09